华东医药
(000963)
| 流通市值：551.53亿 | | | 总市值：552.61亿 |
| 流通股本：17.51亿 | | | 总股本：17.54亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,663,378,011.64 | 3,930,055,822.33 | 4,393,835,953.54 | 2,375,152,352.2 |
| 衍生金融资产 | 16,434,493.97 | 23,781,330.81 | 24,806,772.3 | 29,624,778.28 |
| 应收票据及应收账款 | 7,462,062,780.8 | 8,633,990,884.53 | 7,396,011,322.7 | 8,642,968,121.83 |
| 其中：应收票据 | 6,812,089.97 | 30,000,000 | - | 8,424,980.99 |
| 应收账款 | 7,455,250,690.83 | 8,603,990,884.53 | 7,396,011,322.7 | 8,634,543,140.84 |
| 应收款项融资 | 1,434,366,300.69 | 1,179,728,033.75 | 1,343,534,867.76 | 1,072,015,668.04 |
| 预付款项 | 279,207,655.4 | 391,738,025.42 | 362,087,140 | 558,908,474.57 |
| 其他应收款合计 | 291,135,104.33 | 511,134,375.07 | 553,681,604.74 | 426,378,917.15 |
| 应收股利 | 2,623,608.84 | 223,747.65 | 223,747.65 | 223,747.65 |
| 存货 | 4,290,214,266.03 | 4,889,550,535.88 | 4,600,017,100.8 | 5,055,660,372.2 |
| 其他流动资产 | 59,881,757.08 | 28,009,025.3 | 54,881,711.01 | 154,239,503.07 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 18,496,680,369.94 | 19,587,988,033.09 | 18,728,856,472.85 | 18,314,948,187.34 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,535,907,809.85 | 1,547,325,882.94 | 1,554,304,930.05 | 1,615,531,125.55 |
| 其他权益工具投资 | 565,223,872.68 | 409,199,420.17 | 409,848,691.27 | 409,905,775.09 |
| 投资性房地产 | 12,746,181.87 | 12,957,377 | 13,174,524.11 | 13,391,671.22 |
| 固定资产 | 4,140,144,817.51 | 3,752,658,948.42 | 3,882,268,169.12 | 3,932,528,399.48 |
| 在建工程 | 913,147,212.17 | 1,106,218,018.42 | 995,490,666.09 | 913,273,558.34 |
| 使用权资产 | 151,175,007.16 | 141,069,398 | 140,455,892.14 | 146,533,933.11 |
| 无形资产 | 2,333,787,357.62 | 2,327,531,779.99 | 2,336,097,668.47 | 2,250,237,369.24 |
| 开发支出 | 992,532,091.86 | 784,251,157.61 | 774,096,145.13 | 689,292,520.17 |
| 商誉 | 2,598,696,062.31 | 2,577,647,986.71 | 2,587,351,458.3 | 2,455,916,241.27 |
| 长期待摊费用 | 20,053,854.34 | 20,477,284.51 | 20,981,527.19 | 20,514,237.77 |
| 递延所得税资产 | 187,808,574.44 | 192,386,807.93 | 192,386,807.93 | 153,369,860.61 |
| 其他非流动资产 | 1,561,458,605.23 | 1,532,973,414.69 | 1,320,687,263.41 | 1,199,757,888.07 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 15,012,681,447.04 | 14,404,697,476.39 | 14,227,143,743.21 | 13,800,252,579.92 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 33,509,361,816.98 | 33,992,685,509.48 | 32,956,000,216.06 | 32,115,200,767.26 |
| 流动负债: | | | | |
| 短期借款 | 822,380,292.37 | 813,198,243.24 | 1,052,194,176.07 | 563,013,919.12 |
| 交易性金融负债 | - | 8,970,278.04 | 8,970,278.04 | 14,841,896.97 |
| 衍生金融负债 | - | 490,500 | - | - |
| 应付票据及应付账款 | 6,102,253,940.25 | 6,998,082,244.27 | 6,446,051,394.08 | 6,350,898,410.96 |
| 其中：应付票据 | 1,727,420,960.3 | 2,002,464,644.87 | 1,728,257,564.68 | 1,360,474,461.93 |
| 应付账款 | 4,374,832,979.95 | 4,995,617,599.4 | 4,717,793,829.4 | 4,990,423,949.03 |
| 预收款项 | 1,393,551.48 | 1,975,312.86 | 1,869,073.27 | 881,243.42 |
| 合同负债 | 135,459,275.17 | 167,826,339.02 | 125,334,375.52 | 192,637,694.45 |
| 应付职工薪酬 | 359,148,474.25 | 236,487,492.7 | 215,063,488.67 | 175,666,718.25 |
| 应交税费 | 489,385,055.57 | 403,270,025.35 | 335,297,295.69 | 479,789,639.5 |
| 其他应付款合计 | 2,518,621,382.87 | 2,693,327,807.81 | 2,810,793,780.14 | 2,684,871,969.84 |
| 应付股利 | 143,024,219.6 | 224,219.6 | 224,219.6 | 224,219.6 |
| 一年内到期的非流动负债 | 359,342,623.38 | 299,354,234.55 | 349,680,396.42 | 140,795,971.83 |
| 其他流动负债 | 14,621,494.85 | 20,429,422.29 | 12,763,947.51 | 24,158,784.99 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 10,802,606,090.19 | 11,643,411,900.13 | 11,358,018,205.41 | 10,627,556,249.33 |
| 非流动负债: | | | | |
| 长期借款 | 520,759,460.07 | 728,506,072.02 | 746,918,081.65 | 677,604,268.25 |
| 租赁负债 | 56,695,158.59 | 105,896,905.64 | 92,232,272.51 | 105,228,290.55 |
| 长期应付款 | 107,251,248.59 | 87,266,061.32 | 91,008,860.3 | 289,977,495.12 |
| 预计负债 | 37,184,074.06 | 35,577,667.62 | 41,068,049.26 | 39,859,049.95 |
| 递延收益 | 171,056,435.34 | 175,941,782.72 | 176,825,542.1 | 179,106,792.98 |
| 递延所得税负债 | 184,373,974.04 | 198,336,858.91 | 193,669,206.28 | 202,084,083.93 |
| 其他非流动负债 | 47,170,650 | 78,564,150 | 73,251,500 | 73,251,500 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,124,491,000.69 | 1,410,089,498.23 | 1,414,973,512.1 | 1,567,111,480.78 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 11,927,097,090.88 | 13,053,501,398.36 | 12,772,991,717.51 | 12,194,667,730.11 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,754,425,348 | 1,754,425,348 | 1,753,995,348 | 1,753,995,348 |
| 资本公积 | 2,446,313,774.82 | 2,429,588,311.61 | 2,407,928,799.63 | 2,387,821,545.06 |
| 减:库存股 | 84,519,369.07 | 115,270,300 | 104,645,000 | 104,645,000 |
| 其他综合收益 | -40,341,544.18 | -92,441,607.03 | -91,570,465.5 | -119,904,045.95 |
| 盈余公积 | 1,277,779,972.18 | 1,151,441,705.28 | 1,151,441,705.28 | 1,151,441,705.28 |
| 未分配利润 | 15,693,951,574.91 | 15,170,467,425.8 | 14,415,245,210.75 | 14,245,364,208.58 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 21,047,609,756.66 | 20,298,210,883.66 | 19,532,395,598.16 | 19,314,073,760.97 |
| 少数股东权益 | 534,654,969.44 | 640,973,227.46 | 650,612,900.39 | 606,459,276.18 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 21,582,264,726.1 | 20,939,184,111.12 | 20,183,008,498.55 | 19,920,533,037.15 |
| 负债和股东权益合计 | 33,509,361,816.98 | 33,992,685,509.48 | 32,956,000,216.06 | 32,115,200,767.26 |
| 公告日期 | 2024-04-18 | 2023-10-25 | 2023-08-16 | 2023-04-21 |
| 审计意见(境内) | 标准无保留意见 | | | |